Back to search

Peptide record

TPDB23201

Antibacterial Antiviral Toxicity standard
13 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB23201
Antibacterial Antiviral Toxicity
Anti-infective peptides Toxicity and safety peptides
Peptipedia AI4AVP dbAMP 3.0 DRAVP 2.0
standard
No
A 13-aa standard natural multi-activity (Antibacterial, Antiviral, and Toxicity) peptide sequence curated from Peptipedia, AI4AVP, dbAMP 3.0, and other sources, with an available 3D structural model.
Sequence
LWHHIWNFVHGLI
Physicochemical Analysis
C84H114N22O15
ARDCEQKMPSTY
H
1671.97
8.09
3
0
8
+0
-3.19
0.638
142.31
Mammalian: 5.5 hour Yeast: 3 min E.coli: 2 min
11000
657.91
1
Residue Composition
number
0
A
0
R
1
N
0
D
0
C
0
E
0
Q
1
G
3
H
2
I
2
L
0
K
0
M
1
F
0
P
0
S
0
T
2
W
0
Y
1
V
Amino Acid Distribution
A: 0 R: 0 N: 1 D: 0 C: 0 E: 0 Q: 0 G: 1 H: 3 I: 2 L: 2 K: 0 M: 0 F: 1 P: 0 S: 0 T: 0 W: 2 Y: 0 V: 1
Chemical Descriptors
13
C84H114N22O15
1671.97
8.09
+0
-3.19
0.638
Evidence Records 3 records
Evidence 1 Activity

Activity

50% Cytotoxicity
Toxicity
26.83 µg/mL
Cytotoxic
50% Cytotoxicity | 26.83 | µg/mL | target cell: Vero cells

Target

Vero cells

Source & Reference

NA
DBAASP
Histidine-rich Modification of a Scorpion-derived Peptide Improves Bioavailability and Inhibitory Activity against HSV-1. | Theranostics | 2018
Evidence 2 Activity

Activity

Toxicity
Cytotoxic
Cytotoxicity: [Ref.29290802]Vero cell:CC50=26.83 µg/mL.

Source & Reference

NA
DRAMP
Theranostics. 2018 Jan 1 8(1):199-211.
Evidence 3 Activity

Activity

Toxicity
Cytotoxic
Cytotoxicity: [Ref.29290802]Vero cells: CC50 = 26.83 µg/mL.

Source & Reference

NA
DRAMP
Theranostics. 2018 Jan 1 8(1):199-211.